All In MedTech

Device Trial Radar · NCT07116525

A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter

Clinical Evaluation of Arrhythmia Mapping With a Paddle-shaped, High-density, Multi-electrode Mapping Catheter (an Exploratory Investigation)

Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

90

Planned (sponsor's estimate)

Start

Sep 15, 2025

Primary completion

Feb 7, 2027

Study completion Feb 7, 2027

Sponsor

Lead sponsor
Biosense Webster, Inc.Public (JNJ)
Sponsor type
Industry
First posted
Aug 11, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Device feasibility
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the safety and feasibility of the investigational catheter for mapping the atrial and ventricular regions of the heart.

Conditions

  • Scar-related Atrial Tachycardia
  • Persistent Atrial Fibrillation
  • Paroxysmal Atrial Fibrillation
  • Ventricular Tachycardia
  • Ischemic Ventricular Tachycardia
  • Non-ischemic Ventricular Tachycardia
  • Cardiomyopathy
  • Idiopathic Ventricular Tachycardia
  • Premature Ventricular Contraction

Interventions

  • Paddle-Shaped, High-Density, Multi-Electrode Mapping CatheterDevice

    High-density, multi-electrode mapping catheter will be used for the procedure.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Occurrence of Serious Adverse Events (SAEs) Within 7 Days of Index Procedure Related to the Investigational Catheter When Used for Endocardial MappingTime frame: Up to 7 days post index procedure
  2. Occurrence of Completion of All Pre-Ablation Endocardial Mapping Requirements and Any Clinically Indicated Endocardial MappingTime frame: Up to 7 days post index procedure

Locations

5 sites in 3 countries. Site status is shown where the registry gives one.

  • AZ Sint-Jan

    Bruges, Belgium · Recruiting

  • Jessa Ziekenhuis

    Hasselt, Belgium · Recruiting

  • CHU de Bordeaux - Hospital Haut-Leveque

    Pessac, France · Recruiting

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.